Friday Links – Dulera Approval, It May Not Be Asthma, Fireworks
FDA Approves Dulera, a New Combination Inhaler
Like Advair and Symbicort, the Dulera inhaler contains both a corticosteroid and a long-action beta agonist. According to this article, you should be able to find it in the U.S. soon.
New Anti-Inflammatory Possibly on the Horizon
For patients who can’t get much relief or control from inhaled steroids, this new protein-based therapy, tested in mice, holds some hope.
On the other hand, you’ve got a small chance that persistently uncontrolled asthma may not be another problem entirely:
NEJM Discusses a Benign Tracheal Tumor’s Asthmalike Symptoms
While the passage notes the condition is rare, it also stands a reminder not to rule out other issues that can mimic the symptoms of asthma. Check out the last sentence: “a lack of response to first-line therapies warrants further investigation, including spirographic analysis.”
Finally and because of the Fourth of July in my country this Sunday,
Happy Independence Day, U.S. readers, and enjoy your weekend, everyone. ETA: Happy Canada Day to my northern readers – you know who you are!